.FDA declines experimental MDMA-assisted treatment for post-traumatic stress disorder NBC NewsF.D.A. Downtrends to Approve MDMA Therapy, Looking For Additional Research The Nyc TimesFDA Declines Ecstasy-Based Medicine The Wall Street JournalFDA declines to authorize unique MDMA therapy to deal with post-traumatic stress disorder, along with request for even more litigation information CNNFDA turns down first experimental to alleviate post-traumatic stress disorder, calling for even more study The Washington Post.